Johnson & Johnson logo
Johnson & Johnson
JNJ | NYSE
Chart Builder DCF Calculator
$282.55
-$3.20 (-1.12%)
At close: Nov 16, 2026, 4:00 PM ET
$282.55
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:51 PM ET

Johnson & Johnson Company Profile

Company profile explained

Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Key Executives

Name Position
Joaquin Duato Chief Executive Officer & Chairman
Elizabeth Forminard Executive Vice President & Chief Legal Officer
James Swanson Executive Vice President & Chief Information Officer
Joseph J. Wolk Executive Vice President & Chief Financial Officer
Dirk Brinckman Chief Compliance Officer
John C. Reed Executive Vice President of Innovative Medicine and R&D
Kathryn E. Wengel Executive Vice President and Chief Technical Operations & Risk Officer
Kristen Blair Mulholland Executive Vice President & Chief Human Resources Officer
Robert J. Decker Jr. Controller & Chief Accounting Officer
Ryan Koors Vice President of Investor Relations
Timothy Schmid Executive Vice President & Worldwide Chairman of MedTech

Latest SEC Filings

Date Type Title
Oct 26, 2026 13F-HR Quarterly report filed by institutional managers, ...
Oct 21, 2026 10-Q Quarterly Report
Oct 13, 2026 8-K Current Report
Sep 10, 2026 4 Filing
Sep 10, 2026 4 Filing
Sep 10, 2026 4 Filing
Sep 04, 2026 4 Filing
Sep 01, 2026 3 Filing
Aug 18, 2026 4 Filing
Aug 14, 2026 4 Filing
View All SEC Filings ➞
Johnson & Johnson
Johnson & Johnson logo
Country United States
IPO Date Jan 2, 1962
Industry Drug Manufacturers - General
Sector Healthcare
Employees 141,700
CEO Joaquin Duato

Contact Details

One Johnson & Johnson Plaza New Brunswick, New Jersey 08933 United States

Stock Details

Ticker Symbol JNJ
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000200406
CUSIP Number 478160104
ISIN Number US4781601046
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.